Last updated: 11/04/2018 13:49:45
Effect of a commercial cosmetic mouth rinse on plaque re-growth
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Trial overview
Official title: A clinical study to evaluate the effect of a commercial cosmetic mouth rinse on plaque re-growth
Trial description: A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth
Primary purpose:
Prevention
Trial design:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Allocation:
Randomized
Primary outcomes:
Plaque Index of Test Mouth Rinse versus Sterile Water after Day 4 of treatment administration
Timeframe: Day 4 post treatment administration
Secondary outcomes:
Plaque Index Score of Test Mouth Rinse versus Chlorhexidine Mouth Rinse after Day 4 of treatment administration
Timeframe: Day 4 post treatment administration
Plaque Index after 24 hours of treatment administration
Timeframe: Day 1 post treatment administration
Interproximal Plaque Index after Day 4 of treatment administration
Timeframe: Day 4 post treatment administration
Interproximal Plaque Index after 24 hours of treatment administration
Timeframe: Day 1 post treatment administration
Interventions:
Drug: 0.12% chlorhexidine mouthrinse
Other: Cosmetic mouthrinse
Other: Sterile water
Enrollment:
23
Observational study model:
Not applicable
Primary completion date:
2010-31-05
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Healthy Subjects
Product
Not applicable
Collaborators
Not applicable
Study date(s)
April 2010 to May 2010
Type
Interventional
Phase
2
Participation criteria
Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
Yes
- Inclusion Criteria:
- Good general and oral health
Inclusion and exclusion criteria
Inclusion criteria:
- Inclusion Criteria:
- Good general and oral health
- At least 20 natural gradable teeth
- Mean plaque score (Turesky Modification of the Quigley Hein Index) of greater than or equal to 2.00 at the first baseline visit
Trial location(s)
Location
GSK Investigational Site
Fort Wayne, Indiana, United States, 46825
Status
Study Complete
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Results posted on ClinicalTrials.gov
Recruitment status
Completed
Actual primary completion date
2010-31-05
Actual study completion date
2010-31-05
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website